• Explore /
  • Poster
  • / Hematological profile: A prognosis tool in melanoma patients treated with immunotherapy.

Hematological profile: A prognosis tool in melanoma patients treated with immunotherapy.

Abstract Poster

Authors

null

Soraia Lobo Martins

Oncology Division, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal

Soraia Lobo Martins, Patrícia Miguel-Semedo, Diogo Alexandre Martins-Branco, Ana Maria Monteiro, Cecilia Melo Alvim Moreira, Helena Pais, Ines Vendrell, Andre Mansinho, Emanuel Jose Gouveia, Maria-Jose Saramago Passos, Luis Costa, Ana Rita Teixeira Sousa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Biomarkers and Inflammatory Signatures

Citation

J Clin Oncol 37, 2019 (suppl 8; abstr 135)

DOI

10.1200/JCO.2019.37.8_suppl.135

Abstract #

135

Poster Bd #

E9

Abstract Disclosures

Similar Posters

First Author: Deepak Bhamidipati

Poster

2019 ASCO Annual Meeting

Neutrophil to Lymphocyte ratio (NLR): A prognostic marker in melanoma patients receiving immunotherapy.

Neutrophil to Lymphocyte ratio (NLR): A prognostic marker in melanoma patients receiving immunotherapy.

First Author: Richard Thomas O'Dwyer

First Author: Henry Lu

First Author: David Lynn